Skip to main content
. 2015 Sep 11;10(9):e0136476. doi: 10.1371/journal.pone.0136476

Table 4. The ratio of CD4+ and CD8+ effector T cells in DLBCL primary tissue and peripheral blood.

GCB-DLBCL (n = 8) ABC-DLBCL (n = 12) EBV+DLBCL (n = 7) Healthy control (n = 15)
LN PB LN PB LN PB PB
CD4 Tem/CD4+T(%) 61.20±6.13*** 32.30±5.15 63.91±13.20*** 35.71±8.19 71.73±15.12*** 43.00±7.41 23.31±4.50
CD8 Tem/CD8+T(%) 65.20±8.14*** 36.50±9.15 68.22±12.00*** 39.69±6.79 79.17±11.89*** 44.30±7.83 28.40±6.78

Note: LN: lymph node, PB: peripheral blood, DLBCL: diffuse large B-cell lymphoma, Tem: effector T cells

***P<0.001